Transthyretin deposition in articular cartilage: A novel mechanism in the pathogenesis of osteoarthritis

Yukio Akasaki, Natàlia Reixach, Tokio Matsuzaki, Oscar Alvarez-Garcia, Merissa Olmer, Yukihide Iwamoto, Joel N. Buxbaum, Martin K. Lotz

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective Amyloid deposits are prevalent in osteoarthritic (OA) joints. We undertook this study to define the dominant precursor and to determine whether the deposits affect chondrocyte functions. Methods Amyloid deposition in human normal and OA knee cartilage was determined by Congo red staining. Transthyretin (TTR) in cartilage and synovial fluid was analyzed by immunohistochemistry and Western blotting. The effects of recombinant amyloidogenic and nonamyloidogenic TTR variants were tested in human chondrocyte cultures. Results Normal cartilage from young donors did not contain detectable amyloid deposits, but 7 of 12 aged normal cartilage samples (58%) and 12 of 12 OA cartilage samples (100%) had Congo red staining with green birefringence under polarized light. TTR, which is located predominantly at the cartilage surfaces, was detected in all OA cartilage samples and in a majority of aged normal cartilage samples, but not in normal cartilage samples from young donors. Chondrocytes and synoviocytes did not contain significant amounts of TTR messenger RNA. Synovial fluid TTR levels were similar in normal and OA knees. In cultured chondrocytes, only an amyloidogenic TTR variant induced cell death as well as the expression of proinflammatory cytokines and extracellular matrix-degrading enzymes. The effects of amyloidogenic TTR on gene expression were mediated in part by Toll-like receptor 4, receptor for advanced glycation end products, and p38 MAPK. TTR-induced cytotoxicity was inhibited by resveratrol, a plant polyphenol that stabilizes the native tetrameric structure of TTR. Conclusion These findings are the first to suggest that TTR amyloid deposition contributes to cell and extracellular matrix damage in articular cartilage in human OA and that therapies designed to reduce TTR amyloid formation might be useful.

Original languageEnglish
Pages (from-to)2097-2107
Number of pages11
JournalArthritis and Rheumatology
Volume67
Issue number8
DOIs
Publication statusPublished - Aug 1 2015
Externally publishedYes

Fingerprint

Prealbumin
Articular Cartilage
Osteoarthritis
Cartilage
Chondrocytes
Amyloid
Congo Red
Synovial Fluid
Amyloid Plaques
Extracellular Matrix
Knee
Staining and Labeling
Birefringence
Toll-Like Receptor 4
Polyphenols
p38 Mitogen-Activated Protein Kinases
Cell Death
Joints
Western Blotting
Immunohistochemistry

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Rheumatology
  • Immunology

Cite this

Akasaki, Y., Reixach, N., Matsuzaki, T., Alvarez-Garcia, O., Olmer, M., Iwamoto, Y., ... Lotz, M. K. (2015). Transthyretin deposition in articular cartilage: A novel mechanism in the pathogenesis of osteoarthritis. Arthritis and Rheumatology, 67(8), 2097-2107. https://doi.org/10.1002/art.39178

Transthyretin deposition in articular cartilage : A novel mechanism in the pathogenesis of osteoarthritis. / Akasaki, Yukio; Reixach, Natàlia; Matsuzaki, Tokio; Alvarez-Garcia, Oscar; Olmer, Merissa; Iwamoto, Yukihide; Buxbaum, Joel N.; Lotz, Martin K.

In: Arthritis and Rheumatology, Vol. 67, No. 8, 01.08.2015, p. 2097-2107.

Research output: Contribution to journalArticle

Akasaki, Y, Reixach, N, Matsuzaki, T, Alvarez-Garcia, O, Olmer, M, Iwamoto, Y, Buxbaum, JN & Lotz, MK 2015, 'Transthyretin deposition in articular cartilage: A novel mechanism in the pathogenesis of osteoarthritis', Arthritis and Rheumatology, vol. 67, no. 8, pp. 2097-2107. https://doi.org/10.1002/art.39178
Akasaki, Yukio ; Reixach, Natàlia ; Matsuzaki, Tokio ; Alvarez-Garcia, Oscar ; Olmer, Merissa ; Iwamoto, Yukihide ; Buxbaum, Joel N. ; Lotz, Martin K. / Transthyretin deposition in articular cartilage : A novel mechanism in the pathogenesis of osteoarthritis. In: Arthritis and Rheumatology. 2015 ; Vol. 67, No. 8. pp. 2097-2107.
@article{31038aecbb964861983a918c6395d1d3,
title = "Transthyretin deposition in articular cartilage: A novel mechanism in the pathogenesis of osteoarthritis",
abstract = "Objective Amyloid deposits are prevalent in osteoarthritic (OA) joints. We undertook this study to define the dominant precursor and to determine whether the deposits affect chondrocyte functions. Methods Amyloid deposition in human normal and OA knee cartilage was determined by Congo red staining. Transthyretin (TTR) in cartilage and synovial fluid was analyzed by immunohistochemistry and Western blotting. The effects of recombinant amyloidogenic and nonamyloidogenic TTR variants were tested in human chondrocyte cultures. Results Normal cartilage from young donors did not contain detectable amyloid deposits, but 7 of 12 aged normal cartilage samples (58{\%}) and 12 of 12 OA cartilage samples (100{\%}) had Congo red staining with green birefringence under polarized light. TTR, which is located predominantly at the cartilage surfaces, was detected in all OA cartilage samples and in a majority of aged normal cartilage samples, but not in normal cartilage samples from young donors. Chondrocytes and synoviocytes did not contain significant amounts of TTR messenger RNA. Synovial fluid TTR levels were similar in normal and OA knees. In cultured chondrocytes, only an amyloidogenic TTR variant induced cell death as well as the expression of proinflammatory cytokines and extracellular matrix-degrading enzymes. The effects of amyloidogenic TTR on gene expression were mediated in part by Toll-like receptor 4, receptor for advanced glycation end products, and p38 MAPK. TTR-induced cytotoxicity was inhibited by resveratrol, a plant polyphenol that stabilizes the native tetrameric structure of TTR. Conclusion These findings are the first to suggest that TTR amyloid deposition contributes to cell and extracellular matrix damage in articular cartilage in human OA and that therapies designed to reduce TTR amyloid formation might be useful.",
author = "Yukio Akasaki and Nat{\`a}lia Reixach and Tokio Matsuzaki and Oscar Alvarez-Garcia and Merissa Olmer and Yukihide Iwamoto and Buxbaum, {Joel N.} and Lotz, {Martin K.}",
year = "2015",
month = "8",
day = "1",
doi = "10.1002/art.39178",
language = "English",
volume = "67",
pages = "2097--2107",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "8",

}

TY - JOUR

T1 - Transthyretin deposition in articular cartilage

T2 - A novel mechanism in the pathogenesis of osteoarthritis

AU - Akasaki, Yukio

AU - Reixach, Natàlia

AU - Matsuzaki, Tokio

AU - Alvarez-Garcia, Oscar

AU - Olmer, Merissa

AU - Iwamoto, Yukihide

AU - Buxbaum, Joel N.

AU - Lotz, Martin K.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Objective Amyloid deposits are prevalent in osteoarthritic (OA) joints. We undertook this study to define the dominant precursor and to determine whether the deposits affect chondrocyte functions. Methods Amyloid deposition in human normal and OA knee cartilage was determined by Congo red staining. Transthyretin (TTR) in cartilage and synovial fluid was analyzed by immunohistochemistry and Western blotting. The effects of recombinant amyloidogenic and nonamyloidogenic TTR variants were tested in human chondrocyte cultures. Results Normal cartilage from young donors did not contain detectable amyloid deposits, but 7 of 12 aged normal cartilage samples (58%) and 12 of 12 OA cartilage samples (100%) had Congo red staining with green birefringence under polarized light. TTR, which is located predominantly at the cartilage surfaces, was detected in all OA cartilage samples and in a majority of aged normal cartilage samples, but not in normal cartilage samples from young donors. Chondrocytes and synoviocytes did not contain significant amounts of TTR messenger RNA. Synovial fluid TTR levels were similar in normal and OA knees. In cultured chondrocytes, only an amyloidogenic TTR variant induced cell death as well as the expression of proinflammatory cytokines and extracellular matrix-degrading enzymes. The effects of amyloidogenic TTR on gene expression were mediated in part by Toll-like receptor 4, receptor for advanced glycation end products, and p38 MAPK. TTR-induced cytotoxicity was inhibited by resveratrol, a plant polyphenol that stabilizes the native tetrameric structure of TTR. Conclusion These findings are the first to suggest that TTR amyloid deposition contributes to cell and extracellular matrix damage in articular cartilage in human OA and that therapies designed to reduce TTR amyloid formation might be useful.

AB - Objective Amyloid deposits are prevalent in osteoarthritic (OA) joints. We undertook this study to define the dominant precursor and to determine whether the deposits affect chondrocyte functions. Methods Amyloid deposition in human normal and OA knee cartilage was determined by Congo red staining. Transthyretin (TTR) in cartilage and synovial fluid was analyzed by immunohistochemistry and Western blotting. The effects of recombinant amyloidogenic and nonamyloidogenic TTR variants were tested in human chondrocyte cultures. Results Normal cartilage from young donors did not contain detectable amyloid deposits, but 7 of 12 aged normal cartilage samples (58%) and 12 of 12 OA cartilage samples (100%) had Congo red staining with green birefringence under polarized light. TTR, which is located predominantly at the cartilage surfaces, was detected in all OA cartilage samples and in a majority of aged normal cartilage samples, but not in normal cartilage samples from young donors. Chondrocytes and synoviocytes did not contain significant amounts of TTR messenger RNA. Synovial fluid TTR levels were similar in normal and OA knees. In cultured chondrocytes, only an amyloidogenic TTR variant induced cell death as well as the expression of proinflammatory cytokines and extracellular matrix-degrading enzymes. The effects of amyloidogenic TTR on gene expression were mediated in part by Toll-like receptor 4, receptor for advanced glycation end products, and p38 MAPK. TTR-induced cytotoxicity was inhibited by resveratrol, a plant polyphenol that stabilizes the native tetrameric structure of TTR. Conclusion These findings are the first to suggest that TTR amyloid deposition contributes to cell and extracellular matrix damage in articular cartilage in human OA and that therapies designed to reduce TTR amyloid formation might be useful.

UR - http://www.scopus.com/inward/record.url?scp=84938151998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938151998&partnerID=8YFLogxK

U2 - 10.1002/art.39178

DO - 10.1002/art.39178

M3 - Article

C2 - 25940564

AN - SCOPUS:84938151998

VL - 67

SP - 2097

EP - 2107

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 8

ER -